FDA Grand Rounds: FDA Grand Rounds presented by the Office of Women’s Health: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context and Recent Changes

FDA Grand Rounds presented by the Office of Women’s Health: FDA Menopausal Hormone Therapy (MHT) Labeling: Historical Context and Recent Changes Thursday, April 23, 2026 12:00 p.m. - 1:00 p.m. ET Webcast CME Credit Offered https://www.fda.gov/science-research/about-science-research-fda/fda-grand-rounds?utm_medium=email&utm_source=govdelivery About the Presentation: Join FDA’s Office of Women’s Health (OWH) and the Center for Drug Evaluation and Research (CDER) for an FDA Grand Rounds Webcast on Menopausal Hormone Therapy (MHT). This lecture will provide the historical and regulatory context of MHT which led to the creation of the Women's Health Initiative studies, as well as the results of those studies and the subsequent impact. The lecture will also describe the rationale for the FDA’s requests to update the MHT labeling and describe the labeling changes in each of the 4 MHT product categories.